Trademark: GRAFIXPL PRIME
Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io
Mark Identification
Proof of use for GRAFIXPL PRIME
We do not have any records of a proof of use for GRAFIXPL PRIME at this moment.
Possible trademark infringements of GRAFIXPL PRIME
Basic Information about GRAFIXPL PRIME
- Serial Number
- 87954008
- Filing Date
- 08 Jun 2018
- Registration Number
- 5693652
- Registration Date
- 05 Mar 2019
- Mark Drawing Code
- 4
Classifications
Declare the trademark use of GRAFIXPL PRIME on the blockchain with WikiTrademarks.io.
- First use of GRAFIXPL PRIME anywhere
- GRAFIXPL PRIME was first used on 14 Aug 2018 for the primary classification of goods and services, international, 005 (Pharmaceuticals)
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 005
- US Codes
- 006; 018; 044; 046; 051; 052
Who owns GRAFIXPL PRIME?
1. Osiris Therapeutics, Inc. Columbia MD
2. Osiris Therapeutics, Inc. Columbia MD
3. Osiris Therapeutics, Inc. Columbia MD
Correspondent
- William B. Clemmons Jr.
- Smith & Nephew, Inc.
- 1450 Brooks Road
- Memphis TN 38116
Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io